MSD Innovation Factory: INNOREP Challenge - Creating Memorable Experiences for Healthcare Professionals

MSD Innovation FactoryNowadays, pharmaceutical launches are becoming harder and more competitive. In some cases, MSD products are neither the only nor the first player in the market. Besides, clinical data can be comparable with the products of other laboratories.

Healthcare professionals tend to prescribe the products that they are familiar with and knowledgeable about (what is known as 'top of mind'). Therefore, all pharmaceutical companies focus on face-to-face interaction done by representatives (reps) as an anchor for the exchange of product scientific information with the healthcare professionals.

It is hard for the healthcare professionals to remember the features and value of MSD products due to the limited time they spend with MSD reps, the overall number of reps the see per week (more than 10) together with the cognitive overload and fatigue of dealing with approximately 4 products per interaction.

On average, 87% of healthcare professionals contacts with pharmaceutical sales reps last less than two minutes, which is not enough for impactful product discussion.

Currently MSD sales reps are equipped with Tablets and Laptops for their daily job. However, based on experience, using them in the wrong way can distract the physician from the conversation.

The need
Help MSD reps to set themselves apart from the other reps while interacting with healthcare professionals. MSD is looking for innovative solutions or approaches to support the interaction with healthcare professionals in an ethical unique, engaging and memorable manner.

Expected outputs
Innovative, engaging and impactful solution or approach for having scientific discussions with healthcare professionals and key stakeholders, taking full advantage of the MSD product studies, clinical papers and scientific materials. The solution or approach should be cost-effective. Please refer to the rules for further information on permissible solutions

Deadline date: December 30th 2016, 23:59:59 UTC

For further information and to apply, please visit:
http://www.msdinnovationfactory.com

About MSD (EEMEA)
MSD (in the United States and Canada known as Merck & Co., Inc., Kenilworth, NJ USA) during its 125 years of successful health and medicines innovation achievements is eager to find new and better ways to provide breakthrough medicines and healthcare services to patients and healthcare professionals around the world converging to a new stage of co creation now with the Health Tech Eco System.

That is why the EEMEA (Eastern Europe, Middle East and Africa) MSD Organization is opening the doors for entrepreneurs and ideators to come up with articulable solutions for 3 of our most important needs across all countries within this geographical region. A total of 9 finalists (3 for each need/challenge) will not only have the opportunity to showcase their proposal and debate with MSD experts how to co create together but also will have the chance to earn 3.000€ if selected as the most articulate and innovative solution.

The EEMEA Innovation Factory has been launched in partnership with TICBioMed a Digital Health association specialized in providing business support.

Most Popular Now

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...